Skip to main content

Urinary Retention

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Coloplast
ColoplastAustralia - Mulgrave
2 programs
Investigational device - intermittent catheter with micro-hole zoneN/A1 trial
SpeediCath® cathetersN/A1 trial
Active Trials
NCT05485935Completed73Est. Jan 2023
NCT05065255Unknown250Est. Jan 2023
SRS Medical
SRS MedicalMA - Feeding Hills
1 program
The Spanner Temporary Prostatic StentN/A1 trial
Active Trials
NCT02643849Completed107Est. Feb 2019
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
electrical pudendal nerve stimulationN/A1 trial
Active Trials
NCT06158074Completed70Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Integrated Bioscienceselectrical pudendal nerve stimulation
ColoplastInvestigational device - intermittent catheter with micro-hole zone
ColoplastSpeediCath® catheters
SRS MedicalThe Spanner Temporary Prostatic Stent

Clinical Trials (4)

Total enrollment: 500 patients across 4 trials

NCT06158074Integrated Bioscienceselectrical pudendal nerve stimulation

Efficacy of Electrical Pudendal Nerve Stimulation and Sacral in Treating Non-obstructive Neurogenic Urinary Retention

Start: Jan 2024Est. completion: Dec 202470 patients
N/ACompleted
NCT05485935ColoplastInvestigational device - intermittent catheter with micro-hole zone

A Confirmatory Study Confirming Performance of a New Intermittent Catheter

Start: Aug 2022Est. completion: Jan 202373 patients
N/ACompleted
NCT05065255ColoplastSpeediCath® catheters

Study of the Criteria for Choosing Speedicath Catheters During the Initiation of Self-catheterization

Start: Sep 2021Est. completion: Jan 2023250 patients
N/AUnknown
NCT02643849SRS MedicalThe Spanner Temporary Prostatic Stent

Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men

Start: Aug 2016Est. completion: Feb 2019107 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.